Urocortin-induced relaxation in the human internal mammary artery.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cardiovascular Research

• Publication date

  2005-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CARDIORES.2004.11.018PMID 15721872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators

  2004cited by this paper
• Urocortin and cardiovascular protection.

  2004cited by this paper
• Nickel inhibits urocortin-induced relaxation in the rat pulmonary artery.

  2004cited by this paper
• Roles of cyclic AMP and Ca2+-activated K+ channels in endothelium-independent relaxation by urocortin in the rat coronary artery.

  2003cited by this paper
• Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.

  2002cited by this paper
• Relaxation by urocortin of human saphenous veins

  2002cited by this paper
• Urocortin‐induced endothelium‐dependent relaxation of rat coronary artery: role of nitric oxide and K+ channels

  2002cited by this paper
• Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart.

  2001cited by this paper
• Arterial grafts for coronary surgery: vasospasm and patency rate.

  2001cited by this paper
• Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2

  2000cited by this paper
• Endothelium-dependent hyperpolarization and relaxation resistance to N(G)-nitro-L-arginine and indomethacin in coronary circulation.

  2000cited by this paper
• Endothelium-dependent and -independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery.

  1999cited by this paper
• Actions of CRF and its analogs.

  1999cited by this paper
• Arterial grafts for coronary artery bypass grafting: biological characteristics, functional classification, and clinical choice.

  1999cited by this paper
• A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.

  1999cited by this paper
• Nitric oxide (NO)‐induced activation of large conductance Ca2+‐dependent K+ channels (BKCa) in smooth muscle cells isolated from the rat mesenteric artery

  1998cited by this paper
• Characterization of the relaxant action of urocortin, a new peptide related to corticotropin‐releasing factor in the rat isolated basilar artery

  1998cited by this paper
• Nitric oxide (NO)-induced activation of large conductance Ca2+-dependent K+ channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery.

  1998cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society COMMENTS Vasodilator Actions of Urocortin and Related Peptides in the Human Perfused Placenta in Vitro*

  1998cited by this paper
• Hydroxylamine-induced relaxation inhibited by K+ channel blockers in rat aortic rings.

  1998cited by this paper
• Cardiac inotropic actions of urocortin in conscious sheep.

  1997cited by this paper
• The relaxation responses to corticotropin-releasing factor in rat aorta are endothelium dependent and gestationally regulated.

  1997cited by this paper
• Cloning and characterization of human urocortin [published erratum appears in Endocrinoogy 1996 Sep;137(9):3896]

  1996cited by this paper
• Cloning and characterization of human urocortin.

  1996cited by this paper
• Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate-mediated pathway.

  1995cited by this paper
• Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

  1995cited by this paper
• KCa channel antagonists reduce NO donor-mediated relaxation of vascular and tracheal smooth muscle.

  1995cited by this paper
• Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.

  1994cited by this paper
• Relaxing actions of corticotropin‐releasing factor on rat resistance arteries

  1993cited by this paper
• Regulation of arterial tone by activation of calcium-dependent potassium channels.

  1992cited by this paper
• Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions.

  1991cited by this paper
• Reactivity of human isolated internal mammary artery to constrictor and dilator agents. Implications for treatment of internal mammary artery spasm.

  1989cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

  1982cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin

  1981cited by this paper

• Exploring the Role of Urocortin in Osteoporosis

  2023cites this paper
• Pathophysiology of Preeclampsia and L-Arginine/L-Citrulline Supplementation as a Potential Strategy to Improve Birth Outcomes.

  2023cites this paper
• Cardioprotective and Vasoprotective Effects of Corticotropin-Releasing Hormone and Urocortins: Receptors and Signaling

  2021cites this paper
• Epac-mediated relaxation in murine basilar arteries depends on membrane permeability of cyclic nucleotide analogues and endothelial aging.

  2020cites this paper
• Evaluation of Serum Urocortin 2 Levels in Patients with Hypertension

  2020cites this paper
• Natural and synthetic peptides in the cardiovascular diseases: An update on diagnostic and therapeutic potentials.

  2019cites this paper
• Do urocortins have a role in treating cardiovascular disease?

  2019cites this paper
• Protection of dilator function of coronary arteries from homocysteine by tetramethylpyrazine: Role of ER stress in modulation of BKCa channels.

  2019cites this paper
• Surgical Preparation Reduces Hydrogen Sulfide Released from Human Saphenous Veins in Coronary Artery Bypass Grafting

  2019cites this paper
• Endothelial nitric oxide synthase enhancer AVE3085 reverses endothelial dysfunction induced by homocysteine in human internal mammary arteries.

  2018cites this paper
• Drugs’ development in acute heart failure: what went wrong?

  2018cites this paper
• Urocortins: Actions in health and heart failure.

  2017cites this paper
• Activation of PERK branch of ER stress mediates homocysteine-induced BKCa channel dysfunction in coronary artery via FoxO3a-dependent regulation of atrogin-1.

  2017cites this paper
• Activation of PERK branch of ER stress mediates homocysteine-induced BKCa channel dysfunction in coronary artery via FoxO3a-dependent regulation of atrogin-1

  2017cites this paper
• Cardiovascular effects of the sirtuin and urocortin systems in humans

  2016cites this paper
• Nicorandil directly and cyclic GMP-dependently opens K+ channels in human bypass grafts.

  2015cites this paper
• Abnormal Middle Cerebral Artery Doppler Associates with Spontaneous Preterm Birth in Normally Grown Fetuses

  2015cites this paper
• Urocortin 2 in cardiovascular health and disease.

  2015cites this paper
• Suxiao Jiuxin Pill Induces Potent Relaxation and Inhibition on Contraction in Human Artery and the Mechanism

  2014cites this paper
• Vasoprotective Effects of Urocortin 1 against Atherosclerosis In Vitro and In Vivo

  2014cites this paper
• The role of urocortin-2 in pulmonary arterial hypertension

  2014cites this paper
• The role of urocortins in the cardiovascular system.

  2014cites this paper
• Pharmacology of Arterial Grafts for Coronary Artery Bypass Surgery

  2013cites this paper
• Novel Management of Heart Failure

  2013cites this paper
• New insights into the mechanisms underlying vascular and cardiac effects of urocortin.

  2013cites this paper
• Arterial grafts: clinical classification and pharmacological management.

  2013cites this paper
• Targeting Urocortin Signaling Pathways to Enhance Cardioprotection: Is It Time to Move from Bench to Bedside?

  2013cites this paper
• A New Potential Approach to Inotropic Therapy in the Treatment of Heart Failure: Urocortin

  2013cites this paper
• Therapeutic benefit of urocortin in rats with intracerebral hemorrhage.

  2012cites this paper
• Role of TRPC3 channel in human internal mammary artery.

  2012cites this paper
• Dual actions of cilnidipine in human internal thoracic artery: inhibition of calcium channels and enhancement of endothelial nitric oxide synthase.

  2011cites this paper
• Urocortin‐2 induces vasorelaxation of coronary arteries isolated from patients with heart failure

  2011cites this paper
• Modulation of Calcium Movements by Urocortin II in Endothelial Cells

  2010cites this paper
• Effect of long-term treatment with urocortin on the activity of somatic angiotensin-converting enzyme in spontaneously hypertensive rats.

  2010cites this paper
• Novel neurohormonal insights with therapeutic potential in chronic heart failure.

  2010cites this paper
• Human urotensin II in internal mammary and radial arteries of patients undergoing coronary surgery.

  2010cites this paper
• Urocortin 2 lowers blood pressure and reduces plasma catecholamine levels in mice with hyperadrenergic activity.

  2010cites this paper
• Novel Biomarkers in Cardiovascular Disease: A Review

  2010cites this paper
• Urocortins in heart failure.

  2010cites this paper
• Urocortin II Induces Nitric Oxide Production Through cAMP and Ca2+ Related Pathways in Endothelial Cells

  2009cites this paper
• Novel biomarkers in heart failure: an overview.

  2009cites this paper
• Immediate and Sustained Blood Pressure Lowering by Urocortin 2: A Novel Approach to Antihypertensive Therapy?

  2009cites this paper
• The effect of urocortin II administration on the coronary circulation and cardiac function in the anaesthetized pig is nitric-oxide-dependent.

  2008cites this paper
• Urocortin 1 administration from onset of rapid left ventricular pacing represses progression to overt heart failure.

  2007cites this paper
• Urocortin induces endothelium-dependent vasodilatation and hyperpolarization of rat mesenteric arteries by activating Ca2+-activated K+ channels.

  2007cites this paper
• Vasodilation of retinal arteriole mediated by corticotropin-releasing factor receptor is impaired in streptozotocin-induced diabetic rats.

  2007cites this paper
• Urocortin 2 infusion in human heart failure.

  2007cites this paper
• UROCORTIN 1 ADMINISTRATION FROM ONSET OF RAPID LEFT VENRICULAR PACING REPRESSES PROGRESSION TO OVERT HEART FAILURE

  2007cites this paper
• Role of Ca2+-Independent Phospholipase A2 and Store-Operated Pathway in Urocortin-Induced Vasodilatation of Rat Coronary Artery

  2007cites this paper
• Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

  2007cites this paper
• Clinical research Heart failure / cardiomyopathy Urocortin 2 infusion in human heart failure

  2007cites this paper
• An unusual cause of left atrial mass.

  2007cites this paper
• The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology.

  2006cites this paper
• Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.

  2006cites this paper
• Endothelial Function and Interaction Between the Endothelium and Smooth Muscle in Arterial Grafts

  2006cites this paper
• Clinical Physiology and Related Biological Characteristics

  2006cites this paper
• Effects of intravenous urocortin on angiotensin-converting enzyme in rats.

  2006cites this paper